HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $133,998,000 | +10.0% | 8,322,860 | 0.0% | 3.37% | -13.6% |
| Q4 2018 | $121,763,000 | -18.8% | 8,322,860 | +0.9% | 3.90% | -1.6% |
| Q3 2018 | $149,864,000 | +7.7% | 8,247,860 | 0.0% | 3.97% | -1.3% |
| Q2 2018 | $139,141,000 | -16.6% | 8,247,860 | -3.2% | 4.02% | -12.9% |
| Q1 2018 | $166,909,000 | -3.3% | 8,520,137 | 0.0% | 4.61% | -5.1% |
| Q4 2017 | $172,618,000 | +15.2% | 8,520,137 | -1.2% | 4.86% | +17.2% |
| Q3 2017 | $149,835,000 | +41.4% | 8,626,051 | +4.4% | 4.15% | +28.1% |
| Q2 2017 | $105,961,000 | +5.5% | 8,265,304 | +6.7% | 3.24% | -1.4% |
| Q1 2017 | $100,438,000 | +33.8% | 7,749,832 | +2.0% | 3.28% | +18.1% |
| Q4 2016 | $75,086,000 | -15.8% | 7,599,832 | +3.0% | 2.78% | -11.3% |
| Q3 2016 | $89,148,000 | +40.0% | 7,379,832 | 0.0% | 3.13% | +24.7% |
| Q2 2016 | $63,688,000 | -8.9% | 7,379,832 | 0.0% | 2.51% | -9.5% |
| Q1 2016 | $69,887,000 | -42.6% | 7,379,832 | +5.0% | 2.78% | -19.1% |
| Q4 2015 | $121,827,000 | +30.9% | 7,029,832 | +1.4% | 3.43% | +16.3% |
| Q3 2015 | $93,068,000 | -32.2% | 6,929,832 | +14.0% | 2.95% | -20.7% |
| Q2 2015 | $137,222,000 | +49.6% | 6,077,168 | -5.4% | 3.72% | +36.2% |
| Q1 2015 | $91,726,000 | +39.3% | 6,423,370 | -5.9% | 2.73% | +28.1% |
| Q4 2014 | $65,866,000 | +12.6% | 6,825,532 | +6.1% | 2.13% | -10.3% |
| Q3 2014 | $58,518,000 | +1.3% | 6,430,532 | +10.0% | 2.38% | -13.3% |
| Q2 2014 | $57,764,000 | -19.4% | 5,846,564 | +3.6% | 2.74% | -25.7% |
| Q1 2014 | $71,676,000 | +1.2% | 5,641,564 | +19.4% | 3.70% | -2.4% |
| Q4 2013 | $70,827,000 | +16.3% | 4,724,936 | -14.3% | 3.78% | +14.2% |
| Q3 2013 | $60,900,000 | +35.7% | 5,516,322 | -2.3% | 3.31% | +2.5% |
| Q2 2013 | $44,890,000 | – | 5,646,519 | – | 3.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |